Please provide your email address to receive an email when new articles are posted on . The FDA approved an update to the neffy 1 mg prescribing information so that age is not a factor in when to use ...
PARSIPPANY, N.J., March 24, 2026--(BUSINESS WIRE)--Ferring Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved a label update for ADSTILADRIN ® (nadofaragene ...
Shares of Agios Pharmaceuticals (AGIO) rose ~14% on Tuesday after the company announced plans to seek U.S. accelerated approval for a label expansion of its lead product, Pyrukynd, in sickle cell ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Investing.com - William Blair reiterated an Outperform rating on ARS Pharmaceuticals Inc (NASDAQ:SPRY) following an FDA label update for its product neffy. The FDA label update removes an age ...
Following the Trump administration's plans to explore whether a widely available generic medication called leucovorin could cure autism, GSK (NYSE:GSK), which once manufactured and marketed the ...
A common drug combo for Parkinson’s disease will require a new FDA warning after the agency flagged 14 cases of seizures in patients using the medications. The agency is mandating (PDF) that ...
Ferring Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved a label update for Adstiladrin (nadofaragene firadenovec-vncg), enabling an accelerated water-bath thawing ...
Packaged foods offer convenience for families and individuals, but they can be a major source of saturated fat, sodium and added sugars, which when consumed in excess contribute to chronic disease. To ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results